Pharmaceutical and Biomedical Potential of PEGylated Dendrimers

The development of dendritic architecture with well-defined size, shape and controlled exterior functionality holds promise in pharmaceutical applications such as drug delivery, solubilization, DNA transfection and diagnosis. Highly branched, monodisperse, stable molecular level and low polydispersity with micelle-like behavior possessing nano-scale container property distinguish these structures as inimitable and optimum carrier for those applications. However reticuloendothelial system (RES) uptake, drug leakage, immunogenicity, hemolytic toxicity, cytotoxicity, hydrophobicity restrict the use of these nanostructures. PEGylation of dendrimers can generally overcome these shortcomings. Hemolytic and different cell line studies have shown reduced toxicity of PEGylated dendrimers than cationic dendrimers. PEGylation causes increased solubilization of hydrophobic drugs in dendritic framework as well as in PEG layers. PEGylated dendrimers have proved capable of forming stable complex with plasmid DNA and achieved improved gene transfection as compared to non-PEGylated dendrimers. Attachments of targeting moiety on the surface of partially PEGylated dendrimer created much interest as a delivery system for crossing of biological barriers and deliver the bioactive agent near the vicinity of target site. Recent successes also demonstrate potential of PEGylated dendrimers as magnetic resonance imaging contrast agent and in carbonyl metallo immunoassay. This review focuses on the current state of the art in the field and focuses on the potential of PEGylated dendrimers in pharmaceutical and biomedical area.

[1]  W. Mark Saltzman,et al.  Synthetic DNA delivery systems , 2000, Nature Biotechnology.

[2]  R. Duncan,et al.  Dendrimer biocompatibility and toxicity. , 2005, Advanced drug delivery reviews.

[3]  William A. Goddard,et al.  Starburst Dendrimers: Molecular‐Level Control of Size, Shape, Surface Chemistry, Topology, and Flexibility from Atoms to Macroscopic Matter , 1990 .

[4]  R. Arshady,et al.  Dendrimers, Assemblies, Nanocomposites , 2002 .

[5]  Joseph Zabner,et al.  Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid (*) , 1995, The Journal of Biological Chemistry.

[6]  Markus Biesalski,et al.  Self-assembled monolayers of dendritic polyglycerol derivatives on gold that resist the adsorption of proteins. , 2004, Chemistry.

[7]  Jan-Martin Heldt,et al.  Preparation and characterization of poly(amidoamine) dendrimers functionalized with a rhenium carbonyl complex and PEG as new IR probes for carbonyl metallo immunoassay , 2004 .

[8]  E. W. Meijer,et al.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Chun Li,et al.  Synthesis and characterization of branched poly(L-glutamic acid) as a biodegradable drug carrier. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Donald A Tomalia,et al.  Dendrimers in biomedical applications--reflections on the field. , 2005, Advanced drug delivery reviews.

[11]  K. Kataoka,et al.  Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. , 1997, Bioconjugate chemistry.

[12]  Robert A. Stull,et al.  Antigene, Ribozyme and Aptamer Nucleic Acid Drugs: Progress and Prospects , 1995, Pharmaceutical Research.

[13]  G. Molineux.  The design and development of pegfilgrastim (PEG-rmetHuG-CSF, Neulasta). , 2004, Current pharmaceutical design.

[14]  Anil K Patri,et al.  Dendritic polymer macromolecular carriers for drug delivery. , 2002, Current opinion in chemical biology.

[15]  F. Szoka,et al.  Polyester dendritic systems for drug delivery applications: design, synthesis, and characterization. , 2002, Bioconjugate chemistry.

[16]  J. Fréchet,et al.  Stimuli-Responsive Hybrid Macromolecules: Novel Amphiphilic Star Copolymers With Dendritic Groups at the Periphery , 1996 .

[17]  Luigi Naldini,et al.  Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics , 2001, Nature Medicine.

[18]  G. Blancho,et al.  Immediate and long-term safety of recombinant adeno-associated virus injection into the nonhuman primate muscle. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Dennig,et al.  Gene transfer into eukaryotic cells using activated polyamidoamine dendrimers. , 2002, Journal of biotechnology.

[21]  N. K. Jain,et al.  Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. , 2005, International journal of pharmaceutics.

[22]  Z. Sideratou,et al.  Solubilization and Release Properties of PEGylated Diaminobutane Poly(propylene imine) Dendrimers , 2001 .

[23]  A. Beezer,et al.  Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives , 2003 .

[24]  F. Diederich,et al.  Water‐Soluble Dendritic Iron Porphyrins: Synthetic Models of Globular Heme Proteins , 1996 .

[25]  E. Schacht,et al.  Structure-activity relationships of poly(L-lysines): effects of pegylation and molecular shape on physicochemical and biological properties in gene delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Antony D'Emanuele,et al.  Transport of dendrimer nanocarriers through epithelial cells via the transcellular route. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Hu Yang,et al.  Polyethylene glycol-polyamidoamine dendritic micelle as solubility enhancer and the effect of the length of polyethylene glycol arms on the solubility of pyrene in water. , 2004, Journal of colloid and interface science.

[28]  S. Jain,et al.  A PEGylated dendritic nanoparticulate carrier of fluorouracil. , 2003, International journal of pharmaceutics.

[29]  J A Frank,et al.  Synthesis and relaxometry of high‐generation (G = 5, 7, 9, and 10) PAMAM dendrimer‐DOTA‐gadolinium chelates , 1999, Journal of magnetic resonance imaging : JMRI.

[30]  Jong-sang Park,et al.  Synthesis of a Barbell-like Triblock Copolymer, Poly(l-lysine) Dendrimer-block-Poly(ethylene glycol)-block-Poly(l-lysine) Dendrimer, and Its Self-Assembly with Plasmid DNA , 2000 .

[31]  J. Fréchet,et al.  Novel Polyether Copolymers Consisting of Linear and Dendritic Blocks , 1992 .

[32]  Steve P. Rannard,et al.  Dendrimers: a new class of nanoscopic containers and delivery devices , 2003 .

[33]  T. Timme,et al.  Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice. , 1998, Cancer gene therapy.

[34]  F. Veronese,et al.  Novel monodisperse PEG-dendrons as new tools for targeted drug delivery: synthesis, characterization and cellular uptake. , 2006, Biomacromolecules.

[35]  Clive J Roberts,et al.  Preferential liver gene expression with polypropylenimine dendrimers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Kinam Park,et al.  Effects of ethylene glycol-based graft, star-shaped, and dendritic polymers on solubilization and controlled release of paclitaxel. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[37]  Samuel Zalipsky,et al.  Chemistry of polyethylene glycol conjugates with biologically active molecules , 1995 .

[38]  J. Behr.  SYNTHETIC GENE-TRANSFER VECTORS , 1993 .

[39]  H. Harashima,et al.  Intracellular trafficking and transgene expression of viral and non-viral gene vectors. , 2001, Advanced drug delivery reviews.

[40]  N. K. Jain,et al.  PEGylated dendritic architecture for development of a prolonged drug delivery system for an antitubercular drug. , 2007, Current drug delivery.

[41]  E. Simanek,et al.  Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. , 2004, Journal of the American Chemical Society.

[42]  K. Kono,et al.  Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. , 2000, Bioconjugate chemistry.

[43]  D. Astruc,et al.  Redox-robust pentamethylamidoferrocenyl metallodendrimers that cleanly and selectively recognize the H2PO4- anion. , 2003, Chemical communications.

[44]  N. Jain,et al.  PEGylated Peptide Dendrimeric Carriers for the Delivery of Antimalarial Drug Chloroquine Phosphate , 2005, Pharmaceutical Research.

[45]  M. Ogris,et al.  PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery , 1999, Gene Therapy.

[46]  M. Lotze,et al.  Viruses as gene delivery vectors: Application to gene function, target validation, and assay development , 2002, Cancer Gene Therapy.

[47]  K. Mislick,et al.  Evidence for the role of proteoglycans in cation-mediated gene transfer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  G. Levi,et al.  Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system , 1998, Gene Therapy.

[49]  H. S. Kim,et al.  Affinity biosensor for avidin using a double functionalized dendrimer monolayer on a gold electrode. , 2000, Analytical biochemistry.

[50]  J. V. Hest,et al.  Synthesis, characterization, and guest-host properties of inverted unimolecular dendritic micelles , 1996 .

[51]  M. Hughes,et al.  The cellular delivery of antisense oligonucleotides and ribozymes. , 2001, Drug discovery today.

[52]  E. Meijer,et al.  Encapsulation of Guest Molecules into a Dendritic Box , 1994, Science.

[53]  H. S. Kim,et al.  Functionalization of a poly(amidoamine) dendrimer with ferrocenyls and its application to the construction of a reagentless enzyme electrode. , 2000, Analytical chemistry.

[54]  R. Haag,et al.  Electrolysis as an Efficient Key Step in the Homogeneous Polymer-Supported Synthesis of N-Substituted Pyrroles , 2006 .

[55]  A. Gabizon,et al.  Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[56]  C. Steer,et al.  In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides , 1998, Nature Medicine.

[57]  R. Haag,et al.  High-loading polyglycerol supported reagents for Mitsunobu- and acylation-reactions and other useful polyglycerol derivatives , 2005, Molecular Diversity.

[58]  D. Astruc,et al.  Dendritic catalysts and dendrimers in catalysis. , 2001, Chemical reviews.

[59]  R. Haag,et al.  Highly regioselective synthesis of amino-functionalized dendritic polyglycerols by a one-pot hydroformylation/reductive amination sequence. , 2005, The Journal of organic chemistry.

[60]  D. Fischer,et al.  Synthesis, Characterization, and Biocompatibility of Polyethylenimine-graft-poly(ethylene glycol) Block Copolymers , 2002 .

[61]  Abhay Asthana,et al.  Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled sitespecific delivery of acidic anti-inflammatory active ingredient , 2005, AAPS PharmSciTech.

[62]  R. Haag,et al.  Dendritic polyglycerol sulfates as new heparin analogues and potent inhibitors of the complement system. , 2004, Bioconjugate chemistry.

[63]  F. Szoka,et al.  In vitro gene delivery by degraded polyamidoamine dendrimers. , 1996, Bioconjugate chemistry.

[64]  R. Haag,et al.  Dendritic polyglycerol: a new versatile biocompatible-material. , 2002, Journal of biotechnology.

[65]  R. Haag,et al.  Polystyrene-graft-polyglycerol resins: a new type of high-loading hybrid support for organic synthesis. , 2006, Journal of combinatorial chemistry.

[66]  D. Luo,et al.  Poly(ethylene glycol)-Conjugated PAMAM Dendrimer for Biocompatible, High-Efficiency DNA Delivery , 2002 .

[67]  R. Haag,et al.  Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy. , 2002, Angewandte Chemie.

[68]  J. Reek,et al.  Transition Metal Catalysis Using Functionalized Dendrimers. , 2001, Angewandte Chemie.

[69]  C. Schengrund,et al.  Dendrimers and antivirals: a review. , 2005, Current drug targets. Infectious disorders.

[70]  Francis C Szoka,et al.  Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation. , 2002, Bioconjugate chemistry.

[71]  O. Danos,et al.  Polyethylenimine‐mediated gene delivery: a mechanistic study , 2001, The journal of gene medicine.

[72]  A. Akinc,et al.  Measuring the pH environment of DNA delivered using nonviral vectors: implications for lysosomal trafficking. , 2002, Biotechnology and bioengineering.

[73]  Z. Sideratou,et al.  Acid- and salt-triggered multifunctional poly(propylene imine) dendrimer as a prospective drug delivery system. , 2004, Biomacromolecules.

[74]  F. Szoka,et al.  Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. , 1993, Bioconjugate chemistry.

[75]  M. Brechbiel,et al.  3D‐micro‐MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties , 2001, Magnetic resonance in medicine.

[76]  J. C. Roberts,et al.  Preliminary biological evaluation of polyamidoamine (PAMAM) Starburst dendrimers. , 1996, Journal of biomedical materials research.

[77]  O. Danos,et al.  Intranasal gene delivery with a polyethylenimine-PEG conjugate. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[78]  M. Adeli,et al.  Dendrimers of citric acid and poly (ethylene glycol) as the new drug-delivery agents. , 2005, Biomaterials.

[79]  F. Ledley.  Nonviral gene therapy: the promise of genes as pharmaceutical products. , 1995, Human gene therapy.

[80]  P. Sontum,et al.  Gadolinium(III) DO3A macrocycles and polyethylene glycol coupled to dendrimers : Effect of molecular weight on physical and biological properties of macromolecular magnetic resonance imaging contrast agents , 1997 .

[81]  Fumiyoshi Yamashita,et al.  Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[82]  George R. Newkome,et al.  MICELLES. PART 1. CASCADE MOLECULES: A NEW APPROACH TO MICELLES. A (27)-ARBOROL , 1985 .

[83]  Frank Caruso,et al.  Effect of dendrimer on entrapment and release of bioactive from liposomes. , 2002, International journal of pharmaceutics.

[84]  J. Fréchet,et al.  Designing dendrimers for drug delivery. , 1999, Pharmaceutical science & technology today.

[85]  W. Ford,et al.  Amphiphilic Dendrimers with Both Octyl and Triethylenoxy Methyl Ether Chain Ends , 2000 .

[86]  Feng Liu,et al.  Development of non-viral vectors for systemic gene delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[87]  C. Hawker,et al.  Preparation of polymers with controlled molecular architecture. A new convergent approach to dendritic macromolecules , 1990 .

[88]  Adam Bagg,et al.  Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. , 2003, Molecular genetics and metabolism.

[89]  Hu Yang,et al.  Penicillin V-conjugated PEG-PAMAM star polymers , 2003, Journal of biomaterials science. Polymer edition.

[90]  J. Lehoux,et al.  Some effects of chitosan on liver function in the rat. , 1993, Endocrinology.

[91]  M. Moseley,et al.  Magnetic Resonance Imaging Detection of an Experimental Pulmonary Perfusion Deficit Using a Macromolecular Contrast Agent: Polylysine–Gadolinium-DTPA40 , 1992, Investigative radiology.

[92]  George R. Newkome,et al.  Micelles. Part 1. Cascade molecules: a new approach to micelles. A [27]-arborol , 1985 .

[93]  K. Kono,et al.  Water-soluble dendritic unimolecular micelles: their potential as drug delivery agents. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[94]  H. Ghandehari,et al.  Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers. , 2003, International journal of pharmaceutics.

[95]  K. Ulbrich,et al.  Modification of pLL/DNA complexes with a multivalent hydrophilic polymer permits folate‐mediated targeting in vitro and prolonged plasma circulation in vivo , 2002, The journal of gene medicine.

[96]  P. Heegaard,et al.  Dendrimers in drug research. , 2004, Chemical Society reviews.

[97]  P C Lauterbur,et al.  Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents , 1994, Magnetic resonance in medicine.

[98]  Eichman,et al.  The use of PAMAM dendrimers in the efficient transfer of genetic material into cells. , 2000, Pharmaceutical science & technology today.

[99]  W. Sierralta,et al.  Synthesis of Boron‐Rich Lysine Dendrimers as Protein Labels in Electron Microscopy , 1996 .

[100]  G. Borchard.  Chitosans for gene delivery. , 2001, Advanced drug delivery reviews.

[101]  M. Ogris,et al.  Polylysine-based transfection systems utilizing receptor-mediated delivery. , 1998, Advanced drug delivery reviews.

[102]  T. Kissel,et al.  Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes. , 2006, Bioconjugate chemistry.

[103]  N. Jain,et al.  PEGylated peptide-based dendritic nanoparticulate systems for delivery of artemether , 2005 .

[104]  C. Hawker,et al.  Unimolecular micelles and globular amphiphiles: dendritic macromolecules as novel recyclable solubilization agents , 1993 .

[105]  N. Peppas,et al.  Poly(ethylene glycol)-containing hydrogels in drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[106]  Ijeoma F. Uchegbu,et al.  The Lower-Generation Polypropylenimine Dendrimers Are Effective Gene-Transfer Agents , 2002, Pharmaceutical Research.

[107]  K. Ulbrich,et al.  Characterization of vectors for gene therapy formed by self-assembly of DNA with synthetic block co-polymers. , 1996, Human gene therapy.

[108]  J. Baker,et al.  DNA complexing with polyamidoamine dendrimers: implications for transfection. , 1999, Bioconjugate chemistry.

[109]  K Togashi,et al.  Positive effects of polyethylene glycol conjugation to generation‐4 polyamidoamine dendrimers as macromolecular MR contrast agents , 2001, Magnetic resonance in medicine.

[110]  J. Behr,et al.  Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. , 1996, Gene therapy.

[111]  T. Flotte,et al.  Virus-Based Gene Delivery Systems , 2002, Clinical pharmacokinetics.

[112]  S. Bellone,et al.  Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy. , 2005, Current pharmaceutical design.

[113]  Jindrich Kopecek,et al.  Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. , 2002, Advanced drug delivery reviews.

[114]  Gerrit Borchard,et al.  Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures , 2002, AAPS PharmSci.

[115]  K. Kono,et al.  Water-soluble dendrimer-poly(ethylene glycol) starlike conjugates as potential drug carriers , 1999 .

[116]  M. D. de Villiers,et al.  The effect of PAMAM dendrimer generation size and surface functional group on the aqueous solubility of nifedipine. , 2004, International journal of pharmaceutics.

[117]  M. Conese,et al.  Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs , 2000, Gene Therapy.

[118]  S. Crooke,et al.  An overview of progress in antisense therapeutics. , 1998, Antisense & nucleic acid drug development.

[119]  M. Davis,et al.  Cationic polymers for gene delivery: designs for overcoming barriers to systemic administration. , 2001, Current opinion in molecular therapeutics.

[120]  D. Burgess,et al.  DNA-based therapeutics and DNA delivery systems: A comprehensive review , 2005, The AAPS Journal.

[121]  J. S. Choi,et al.  Poly(ethylene glycol)-block-poly(L-lysine) dendrimer: novel linear polymer/dendrimer block copolymer forming a spherical water-soluble polyionic complex with DNA. , 1999, Bioconjugate chemistry.

[122]  Hu Yang,et al.  In vitro enzymatic stability of dendritic peptides. , 2006, Journal of biomedical materials research. Part A.

[123]  Lemkine Gf,et al.  Polyethylenimines for in vivo gene delivery. , 2001 .

[124]  Anil K Patri,et al.  Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. , 2005, Advanced drug delivery reviews.

[125]  J. Fréchet,et al.  Dendrimers and dendritic polymers in drug delivery. , 2005, Drug discovery today.

[126]  N. McKeown,et al.  The influence of surface modification on the cytotoxicity of PAMAM dendrimers. , 2003, International journal of pharmaceutics.

[127]  Ruth Duncan,et al.  Anionic PAMAM Dendrimers Rapidly Cross Adult Rat Intestine In Vitro: A Potential Oral Delivery System? , 2000, Pharmaceutical Research.

[128]  N. Hylton,et al.  Evaluation of the effects of intravascular MR contrast media (gadolinium dendrimer) on 3D time of flight magnetic resonance angiography of the body , 1996, Journal of magnetic resonance imaging : JMRI.